Lunai Bioworks (LNAI) Cash from Financing Activities (2011 - 2026)

Lunai Bioworks' Cash from Financing Activities history runs 16 years deep, the most recent figure standing at $3.7 million for Q1 2026.

• In Q1 2026, Cash from Financing Activities rose 3.33% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $6.2 million (down 42.13% YoY), while the FY2025 annual figure was $8.4 million, down 20.3% from the prior year.
• Cash from Financing Activities for Q1 2026 stood at $3.7 million, up from $950000.0 in the prior quarter.
• The five-year high for Cash from Financing Activities was $3.7 million in Q1 2026, with the low at -$300000.0 in Q4 2022.
• The 5-year median for Cash from Financing Activities is $2.0 million (2024), against an average of $1.8 million.
• The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities sank 110.17% in 2022, then soared 1048.96% in 2023.
• Lunai Bioworks' Cash from Financing Activities stood at -$300000.0 in 2022, then jumped by 1048.96% to $2.8 million in 2023, then decreased by 8.99% to $2.6 million in 2024, then sank by 63.33% to $950000.0 in 2025, then jumped by 289.84% to $3.7 million in 2026.
• Business Quant data shows LNAI's Cash from Financing Activities at $3.7 million in Q1 2026, $950000.0 in Q4 2025, and $1.3 million in Q3 2025.